Gaps in access to care persist for US patients with MS and impact HRQOL to a large extent. Improving access to care for patients with MS should be prioritized.

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according ...

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

The increasing prevalence of autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis, driven by genetic, environmental, and lifestyle factors, underscores the necessity for ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...

This explanation challenges the results from previous randomised controlled trials and the efficacy of all approved drugs, ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting ...

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...